SCHEMBL19014644

SCHEMBL19014644

CCCN(CCNC(=O)OCc1ccccc1)CP(=O)(O)OCC

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ HTT P42858 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ MAPT P10636 1/20 0.45
▸ CTSL P07711 1/20 0.44
▸ CTSB P07858 1/20 0.44
▸ CTSS P25774 1/20 0.44
▸ CTSK P43235 1/20 0.44
▸ KEAP1 Q14145 2/20 0.43
▸ NFE2L2 Q16236 2/20 0.43
▸ CETP P11597 3/20 0.43
▸ TGM2 P21980 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19014710 0.81 LMNA (0.40) LMNASMN1; SMN2HTTHSD17B10L3MBTL1
SCHEMBL1442202 0.81 LMNA (0.56) LMNASMN1; SMN2HTTHSD17B10L3MBTL1
SCHEMBL13725441 0.80 HTT (0.59) LMNASMN1; SMN2HTTHSD17B10L3MBTL1
SCHEMBL19014642 0.80 HSD17B10 (0.42) LMNASMN1; SMN2HTTHSD17B10L3MBTL1
SCHEMBL12304971 0.76 LMNA (0.58) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL21338346 0.76 LMNA (0.55) LMNASMN1; SMN2HTTHSD17B10L3MBTL1
SCHEMBL9932079 0.76 LMNA (0.62) LMNASMN1; SMN2HTTHSD17B10L3MBTL1
SCHEMBL27479706 0.75 LMNA (0.57) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL1439677 0.75 LMNA (0.57) LMNASMN1; SMN2HTTHSD17B10L3MBTL1
SCHEMBL25851930 0.75 SLC1A3 (0.50) LMNASMN1; SMN2HTTL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017101851-A1 ACYLSULFONAMIDE DERIVATIVES FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS UNITY BIOTECHNOLOGY, INC. (US) 2017-06-22 — — WO disclosed
Send feedback